Free Trial

This company has been marked as potentially delisted and may not be actively trading.

DFP Healthcare Acquisitions (DFPH) Competitors

DFPH vs. PDEX, DCGO, ACHV, MOLN, CLYM, NKTX, BSGM, THTX, MXCT, and LNSR

Should you be buying DFP Healthcare Acquisitions stock or one of its competitors? The main competitors of DFP Healthcare Acquisitions include Pro-Dex (PDEX), DocGo (DCGO), Achieve Life Sciences (ACHV), Molecular Partners (MOLN), Climb Bio (CLYM), Nkarta (NKTX), Biosig Technologies (BSGM), Theratechnologies (THTX), MaxCyte (MXCT), and LENSAR (LNSR). These companies are all part of the "medical" sector.

DFP Healthcare Acquisitions vs. Its Competitors

Pro-Dex (NASDAQ:PDEX) and DFP Healthcare Acquisitions (NASDAQ:DFPH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

Pro-Dex has a net margin of 13.48% compared to DFP Healthcare Acquisitions' net margin of 0.00%. Pro-Dex's return on equity of 26.67% beat DFP Healthcare Acquisitions' return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex13.48% 26.67% 14.95%
DFP Healthcare Acquisitions N/A -107.60%-1.47%

Pro-Dex currently has a consensus price target of $56.00, suggesting a potential upside of 69.34%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts plainly believe Pro-Dex is more favorable than DFP Healthcare Acquisitions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
DFP Healthcare Acquisitions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Pro-Dex had 4 more articles in the media than DFP Healthcare Acquisitions. MarketBeat recorded 4 mentions for Pro-Dex and 0 mentions for DFP Healthcare Acquisitions. Pro-Dex's average media sentiment score of 0.89 beat DFP Healthcare Acquisitions' score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media.

Company Overall Sentiment
Pro-Dex Positive
DFP Healthcare Acquisitions Neutral

Pro-Dex has a beta of -0.04, indicating that its share price is 104% less volatile than the S&P 500. Comparatively, DFP Healthcare Acquisitions has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500.

Pro-Dex has higher revenue and earnings than DFP Healthcare Acquisitions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$66.59M1.62$8.98M$2.7012.25
DFP Healthcare AcquisitionsN/AN/A-$8.34MN/AN/A

15.3% of Pro-Dex shares are held by institutional investors. 47.5% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Pro-Dex beats DFP Healthcare Acquisitions on 12 of the 13 factors compared between the two stocks.

Get DFP Healthcare Acquisitions News Delivered to You Automatically

Sign up to receive the latest news and ratings for DFPH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DFPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DFPH vs. The Competition

MetricDFP Healthcare AcquisitionsOffices & Clinics Of Medical Doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$38.53M$33.61M$5.84B$10.14B
Dividend YieldN/AN/A5.68%4.60%
P/E RatioN/AN/A75.4125.98
Price / SalesN/A0.60515.81181.13
Price / CashN/A54.0337.5660.44
Price / Book-1.540.3912.156.29
Net Income-$8.34M-$7.06M$3.29B$271.07M

DFP Healthcare Acquisitions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DFPH
DFP Healthcare Acquisitions
N/A$1.34
flat
N/AN/A$38.53MN/A0.00147,000
PDEX
Pro-Dex
2.8729 of 5 stars
$46.47
+0.9%
$56.00
+20.5%
+23.9%$152.88M$53.84M16.60140News Coverage
Positive News
DCGO
DocGo
2.5014 of 5 stars
$1.55
+0.6%
$3.59
+131.6%
-58.1%$152.58M$616.55M-8.164,407News Coverage
Positive News
ACHV
Achieve Life Sciences
2.2351 of 5 stars
$2.86
-2.1%
$14.67
+412.8%
-32.0%$152.29MN/A-1.9620News Coverage
Short Interest ↑
High Trading Volume
MOLN
Molecular Partners
2.5641 of 5 stars
$3.73
-1.9%
$8.00
+114.7%
-29.6%$151.40M$5.65M-1.79180Gap Up
CLYM
Climb Bio
3.7033 of 5 stars
$2.44
+9.4%
$9.00
+268.9%
N/A$151.11MN/A-3.499News Coverage
Positive News
NKTX
Nkarta
2.3358 of 5 stars
$2.10
flat
$13.60
+547.6%
-65.5%$150.57MN/A-1.42140Positive News
BSGM
Biosig Technologies
2.0566 of 5 stars
$4.71
-0.4%
$10.00
+112.3%
+1,316.9%$150.18M$40K0.0050Gap Down
THTX
Theratechnologies
N/A$3.24
-0.3%
N/A+144.4%$148.98M$85.87M-17.05140News Coverage
Short Interest ↓
MXCT
MaxCyte
3.8631 of 5 stars
$1.38
+3.0%
$7.00
+407.2%
-64.0%$148.18M$38.63M-3.2180Positive News
LNSR
LENSAR
1.5459 of 5 stars
$12.04
-2.5%
$15.00
+24.6%
+146.4%$146.56M$53.49M-2.86110News Coverage
Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:DFPH) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners